Literature DB >> 31661051

To TRIM or not to TRIM: the balance of host-virus interactions mediated by the ubiquitin system.

Adam Hage1, Ricardo Rajsbaum1,2.   

Abstract

The innate immune system responds rapidly to protect against viral infections, but an overactive response can cause harmful damage. To avoid this, the response is tightly regulated by post-translational modifications (PTMs). The ubiquitin system represents a powerful PTM machinery that allows for the reversible linkage of ubiquitin to activate and deactivate a target's function. A precise enzymatic cascade of ubiquitin-activating, conjugating and ligating enzymes facilitates ubiquitination. Viruses have evolved to take advantage of the ubiquitin pathway either by targeting factors to dampen the antiviral response or by hijacking the system to enhance their replication. The tripartite motif (TRIM) family of E3 ubiquitin ligases has garnered attention as a major contributor to innate immunity. Many TRIM family members limit viruses either indirectly as components in innate immune signalling, or directly by targeting viral proteins for degradation. In spite of this, TRIMs and other ubiquitin ligases can be appropriated by viruses and repurposed as valuable tools in viral replication. This duality of function suggests a new frontier of research for TRIMs and raises new challenges for discerning the subtleties of these pro-viral mechanisms. Here, we review current findings regarding the involvement of TRIMs in host-virus interactions. We examine ongoing developments in the field, including novel roles for unanchored ubiquitin in innate immunity, the direct involvement of ubiquitin ligases in promoting viral replication, recent controversies on the role of ubiquitin and TRIM25 in activation of the pattern recognition receptor RIG-I, and we discuss the implications these studies have on future research directions.

Entities:  

Keywords:  E3 ubiquitin ligase; innate immunity; tripartite motif (TRIM); ubiquitin; unanchored polyubiquitin; virus infection

Mesh:

Substances:

Year:  2019        PMID: 31661051      PMCID: PMC7011758          DOI: 10.1099/jgv.0.001341

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  200 in total

1.  TRIM5α-Mediated Ubiquitin Chain Conjugation Is Required for Inhibition of HIV-1 Reverse Transcription and Capsid Destabilization.

Authors:  Edward M Campbell; Jared Weingart; Paola Sette; Silvana Opp; Jaya Sastri; Sarah K O'Connor; Sarah Talley; Felipe Diaz-Griffero; Vanessa Hirsch; Fadila Bouamr
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

2.  Hexagonal assembly of a restricting TRIM5alpha protein.

Authors:  Barbie K Ganser-Pornillos; Viswanathan Chandrasekaran; Owen Pornillos; Joseph G Sodroski; Wesley I Sundquist; Mark Yeager
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

3.  TRIM52: A nuclear TRIM protein that positively regulates the nuclear factor-kappa B signaling pathway.

Authors:  Wenchun Fan; Tingting Liu; Xiangmin Li; Yun Zhou; Mengge Wu; Xiaofang Cui; Huanchun Chen; Ping Qian
Journal:  Mol Immunol       Date:  2017-01-07       Impact factor: 4.407

4.  Siglec1 suppresses antiviral innate immune response by inducing TBK1 degradation via the ubiquitin ligase TRIM27.

Authors:  Qingliang Zheng; Jin Hou; Ye Zhou; Yingyun Yang; Bing Xie; Xuetao Cao
Journal:  Cell Res       Date:  2015-09-11       Impact factor: 25.617

5.  Caspase-12 controls West Nile virus infection via the viral RNA receptor RIG-I.

Authors:  Penghua Wang; Alvaro Arjona; Yue Zhang; Hameeda Sultana; Jianfeng Dai; Long Yang; Philippe M LeBlanc; Karine Doiron; Maya Saleh; Erol Fikrig
Journal:  Nat Immunol       Date:  2010-09-05       Impact factor: 25.606

6.  FTR83, a Member of the Large Fish-Specific finTRIM Family, Triggers IFN Pathway and Counters Viral Infection.

Authors:  Christelle Langevin; Elina Aleksejeva; Armel Houel; Valérie Briolat; Corinne Torhy; Aurélie Lunazzi; Jean-Pierre Levraud; Pierre Boudinot
Journal:  Front Immunol       Date:  2017-05-26       Impact factor: 7.561

Review 7.  The TRIMendous Role of TRIMs in Virus-Host Interactions.

Authors:  Sarah van Tol; Adam Hage; Maria Isabel Giraldo; Preeti Bharaj; Ricardo Rajsbaum
Journal:  Vaccines (Basel)       Date:  2017-08-22

8.  Ubiquitination Is Essential for Avibirnavirus Replication by Supporting VP1 Polymerase Activity.

Authors:  Huansheng Wu; Liuyuan Shi; Yina Zhang; Xiran Peng; Tuyuan Zheng; Yahui Li; Boli Hu; Xiaojuan Zheng; Jiyong Zhou
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

9.  NDR2 promotes the antiviral immune response via facilitating TRIM25-mediated RIG-I activation in macrophages.

Authors:  Zhiyong Liu; Cheng Wu; Yueyun Pan; Huan Liu; Xiumei Wang; Yuting Yang; Meidi Gu; Yuanyuan Zhang; Xiaojian Wang
Journal:  Sci Adv       Date:  2019-02-06       Impact factor: 14.136

10.  TRIM14 expression is regulated by IRF-1 and IRF-2.

Authors:  Jingang Cui; Xiao Xu; Yutong Li; Xiaomei Hu; Yingpeng Xie; Juan Tan; Wentao Qiao
Journal:  FEBS Open Bio       Date:  2019-07-01       Impact factor: 2.693

View more
  25 in total

1.  Exploiting Ubiquitin Ligases for Induced Target Degradation as an Antiviral Strategy.

Authors:  Rati Verma
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  A RIG-I-like receptor directs antiviral responses to a bunyavirus and is antagonized by virus-induced blockade of TRIM25-mediated ubiquitination.

Authors:  Yuan-Qin Min; Yun-Jia Ning; Hualin Wang; Fei Deng
Journal:  J Biol Chem       Date:  2020-05-29       Impact factor: 5.157

3.  Mapping of molecular interactions between human E3 ligase TRIM69 and Dengue virus NS3 protease using hydrogen-deuterium exchange mass spectrometry.

Authors:  Tanaya Bagga; Nikhil Kumar Tulsian; Yu Keung Mok; R Manjunatha Kini; J Sivaraman
Journal:  Cell Mol Life Sci       Date:  2022-04-10       Impact factor: 9.261

4.  C-terminal glutamine acts as a C-degron targeted by E3 ubiquitin ligase TRIM7.

Authors:  Yawei Ru; Xiaojie Yan; Bing Zhang; Lili Song; Qiqi Feng; Chen Ye; Zhili Zhou; Zhenzhen Yang; Yao Li; Zhenjian Zhang; Qianqian Li; Wenyi Mi; Cheng Dong
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-22       Impact factor: 12.779

5.  A C-terminal glutamine recognition mechanism revealed by E3 ligase TRIM7 structures.

Authors:  Xiao Liang; Jun Xiao; Xuzichao Li; Yujie Liu; Yao Lu; Yanan Wen; Zexing Li; Xing Che; Yongjian Ma; Xingyan Zhang; Yi Zhang; Deng Jian; Peihui Wang; Chenghao Xuan; Guimei Yu; Long Li; Heng Zhang
Journal:  Nat Chem Biol       Date:  2022-08-18       Impact factor: 16.174

6.  Avian Influenza NS1 Proteins Inhibit Human, but Not Duck, RIG-I Ubiquitination and Interferon Signaling.

Authors:  Danyel Evseev; Domingo Miranzo-Navarro; Ximena Fleming-Canepa; Robert G Webster; Katharine E Magor
Journal:  J Virol       Date:  2022-09-07       Impact factor: 6.549

Review 7.  Dual-Role Ubiquitination Regulation Shuttling the Entire Life Cycle of the Flaviviridae.

Authors:  Dongjie Cai; Lingli Liu; Bin Tian; Xingxin Fu; Qiyuan Yang; Jie Chen; Yilin Zhang; Jing Fang; Liuhong Shen; Ya Wang; Liping Gou; Zhicai Zuo
Journal:  Front Microbiol       Date:  2022-05-06       Impact factor: 6.064

8.  TRIM28 functions as a negative regulator of aggresome formation.

Authors:  Jeeyoon Chang; Hyun Jung Hwang; Byungju Kim; Yeon-Gil Choi; Joori Park; Yeonkyoung Park; Ban Seok Lee; Heedo Park; Min Ji Yoon; Jae-Sung Woo; Chungho Kim; Man-Seong Park; Jong-Bong Lee; Yoon Ki Kim
Journal:  Autophagy       Date:  2021-04-12       Impact factor: 16.016

9.  Knockdown of TRIM5α or TRIM11 increases lentiviral vector transduction efficiency of human Muller cells.

Authors:  Monica M Sauter; Curtis R Brandt
Journal:  Exp Eye Res       Date:  2021-01-10       Impact factor: 3.467

10.  TRIM7 inhibits enterovirus replication and promotes emergence of a viral variant with increased pathogenicity.

Authors:  Wenchun Fan; Katrina B Mar; Levent Sari; Ilona K Gaszek; Qiang Cheng; Bret M Evers; John M Shelton; Mary Wight-Carter; Daniel J Siegwart; Milo M Lin; John W Schoggins
Journal:  Cell       Date:  2021-05-31       Impact factor: 66.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.